In the 2022 fiscal year, the leading product in terms of sales of the Japanese pharmaceutical company Takeda Pharmaceutical Co., Ltd. was Entyvio, with a sales value of more than *** billion Japanese yen. Entyvio is a prescription drug treating adult patients with ulcerative colitis and Crohn's disease.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆÆ½â°æ can support your business.
Takeda Pharmaceutical Company. (November 28, 2023). Global major products' sales revenue of Takeda Pharmaceutical Co., Ltd. in fiscal year 2022 (in billion Japanese yen) [Graph]. In ÌÇÐÄÆÆ½â°æ. Retrieved July 30, 2026, from /statistics/878059/takeda-pharmaceutical-global-major-products-sales/
Takeda Pharmaceutical Company. "Global major products' sales revenue of Takeda Pharmaceutical Co., Ltd. in fiscal year 2022 (in billion Japanese yen)." Chart. November 28, 2023. ÌÇÐÄÆÆ½â°æ. Accessed July 30, 2026. /statistics/878059/takeda-pharmaceutical-global-major-products-sales/
Takeda Pharmaceutical Company. (2023). Global major products' sales revenue of Takeda Pharmaceutical Co., Ltd. in fiscal year 2022 (in billion Japanese yen). ÌÇÐÄÆÆ½â°æ. ÌÇÐÄÆÆ½â°æ Inc.. Accessed: July 30, 2026. /statistics/878059/takeda-pharmaceutical-global-major-products-sales/
Takeda Pharmaceutical Company. "Global Major Products' Sales Revenue of Takeda Pharmaceutical Co., Ltd. in Fiscal Year 2022 (in Billion Japanese Yen)." ÌÇÐÄÆÆ½â°æ, ÌÇÐÄÆÆ½â°æ Inc., 28 Nov 2023, /statistics/878059/takeda-pharmaceutical-global-major-products-sales/
Takeda Pharmaceutical Company, Global major products' sales revenue of Takeda Pharmaceutical Co., Ltd. in fiscal year 2022 (in billion Japanese yen) ÌÇÐÄÆÆ½â°æ, /statistics/878059/takeda-pharmaceutical-global-major-products-sales/ (last visited July 30, 2026)
Global major products' sales revenue of Takeda Pharmaceutical Co., Ltd. in fiscal year 2022 (in billion Japanese yen) [Graph], Takeda Pharmaceutical Company, November 28, 2023. [Online]. Available: /statistics/878059/takeda-pharmaceutical-global-major-products-sales/